398 related articles for article (PubMed ID: 33794332)
1. Mitochondria: The metabolic switch of cellular oncogenic transformation.
Tan YQ; Zhang X; Zhang S; Zhu T; Garg M; Lobie PE; Pandey V
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188534. PubMed ID: 33794332
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria and Cancer.
Zong WX; Rabinowitz JD; White E
Mol Cell; 2016 Mar; 61(5):667-676. PubMed ID: 26942671
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
4. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
[TBL] [Abstract][Full Text] [Related]
5. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
6. Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer.
Yi HS; Chang JY; Kim KS; Shong M
Korean J Intern Med; 2017 Sep; 32(5):780-789. PubMed ID: 28823142
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial ROS control of cancer.
Idelchik MDPS; Begley U; Begley TJ; Melendez JA
Semin Cancer Biol; 2017 Dec; 47():57-66. PubMed ID: 28445781
[TBL] [Abstract][Full Text] [Related]
8. ROS, autophagy, mitochondria and cancer: Ras, the hidden master?
Bellot GL; Liu D; Pervaiz S
Mitochondrion; 2013 May; 13(3):155-62. PubMed ID: 22750269
[TBL] [Abstract][Full Text] [Related]
9. The oncogenic role of HBXIP.
Xiu M; Zeng X; Shan R; Wen W; Li J; Wan R
Biomed Pharmacother; 2021 Jan; 133():111045. PubMed ID: 33378953
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial determinants of cancer health disparities.
Choudhury AR; Singh KK
Semin Cancer Biol; 2017 Dec; 47():125-146. PubMed ID: 28487205
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming Oxidative Phosphorylation in Cancer: A Role for RNA-Binding Proteins.
Esparza-Moltó PB; Cuezva JM
Antioxid Redox Signal; 2020 Nov; 33(13):927-945. PubMed ID: 31910046
[No Abstract] [Full Text] [Related]
12. Mitochondrial Tumor Suppressors-The Energetic Enemies of Tumor Progression.
Jakoube P; Cutano V; González-Morena JM; Keckesova Z
Cancer Res; 2021 Sep; 81(18):4652-4667. PubMed ID: 34183354
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated metabolism contributes to oncogenesis.
Hirschey MD; DeBerardinis RJ; Diehl AME; Drew JE; Frezza C; Green MF; Jones LW; Ko YH; Le A; Lea MA; Locasale JW; Longo VD; Lyssiotis CA; McDonnell E; Mehrmohamadi M; Michelotti G; Muralidhar V; Murphy MP; Pedersen PL; Poore B; Raffaghello L; Rathmell JC; Sivanand S; Vander Heiden MG; Wellen KE;
Semin Cancer Biol; 2015 Dec; 35 Suppl():S129-S150. PubMed ID: 26454069
[TBL] [Abstract][Full Text] [Related]
14. The role of compartmentalized signaling pathways in the control of mitochondrial activities in cancer cells.
Rinaldi L; Delle Donne R; Borzacchiello D; Insabato L; Feliciello A
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):293-302. PubMed ID: 29673970
[TBL] [Abstract][Full Text] [Related]
15. To betray or to fight? The dual identity of the mitochondria in cancer.
Zhang X; Su Q; Zhou J; Yang Z; Liu Z; Ji L; Gao H; Jiang G
Future Oncol; 2021 Feb; 17(6):723-743. PubMed ID: 33459048
[TBL] [Abstract][Full Text] [Related]
16. RAS-mediated oncogenic signaling pathways in human malignancies.
Khan AQ; Kuttikrishnan S; Siveen KS; Prabhu KS; Shanmugakonar M; Al-Naemi HA; Haris M; Dermime S; Uddin S
Semin Cancer Biol; 2019 Feb; 54():1-13. PubMed ID: 29524560
[TBL] [Abstract][Full Text] [Related]
17. A Synthetic Lethal Interaction between Glutathione Synthesis and Mitochondrial Reactive Oxygen Species Provides a Tumor-Specific Vulnerability Dependent on STAT3.
Garama DJ; Harris TJ; White CL; Rossello FJ; Abdul-Hay M; Gough DJ; Levy DE
Mol Cell Biol; 2015 Nov; 35(21):3646-56. PubMed ID: 26283727
[TBL] [Abstract][Full Text] [Related]
18. Learning from oncocytic tumors: Why choose inefficient mitochondria?
Gasparre G; Romeo G; Rugolo M; Porcelli AM
Biochim Biophys Acta; 2011 Jun; 1807(6):633-42. PubMed ID: 20732299
[TBL] [Abstract][Full Text] [Related]
19. The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism.
Rogalinska M
Mini Rev Med Chem; 2016; 16(7):524-30. PubMed ID: 26471969
[TBL] [Abstract][Full Text] [Related]
20. Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target.
Infantino V; Santarsiero A; Convertini P; Todisco S; Iacobazzi V
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
